Navigation Links
Announcing the 1st IOF-ESCEO Pre-Clinical Symposium
Date:6/24/2010

The International Osteoporosis Foundation (IOF) is pleased to announce the inaugural IOF-ESCEO Pre-Clinical Symposium a new forum for the best pre-clinical and translational science in bone biology to be held from March 22-23, 2011, immediately preceding the European Congress on Osteoporosis and Osteoarthritis (ECCEO11-IOF) in Valencia .

The Symposium will be chaired by Gerard Karsenty, Professor and Chair, Genetics & Development, Columbia University MC one of the world's leading scientists from the bone biology arena. The Symposium will feature four hours of lectures by invited key opinion leaders, held in an informal setting to encourage discussion and stimulating interaction. Most importantly, the Symposium will provide an outstanding opportunity for young investigators to showcase their latest research in over eight hours of oral presentations, selected from the highest ranked abstracts. In order to support the travel costs of researchers, IOF and ESCEO will award 500 Euro travel grants to the scientists selected for oral presentations.

Pure science no distractions:

Scientists engaged in pre-clinical research in osteoporosis, osteoarthritis and related metabolic bone diseases are invited to take this opportunity to present and discuss their latest research findings with other investigators and key opinion leaders. The organizers intend to create a uniquely intimate, stimulating environment focused purely on science with no exhibitions or other distractions.

Registrants to the 1st Pre-Clinical Symposium may opt to attend the ECCEO11-IOF from March 23-26, 2011 at a significantly reduced registration rate.


'/>"/>

Contact: L. Misteli
news@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. IUs Carlson among team of scientists announcing new species of prehistoric man
2. New dinosaur rears its head; U-M researchers part of team announcing find
3. Announcing IOF Regionals 1st Asia-Pacific osteoporosis meeting
4. Announcing the new Journal of Integrated Pest Management
5. A missing enzyme conveys major heart protection in pre-clinical work
6. Alzheimers disease therapeutic prevents long-term damage from TBI in pre-clinical studies
7. Prosthetic vein valve designed to direct blood flow shows promising pre-clinical results
8. Singulex Teams With Wyeth Pharmaceuticals to Translate Pre-Clinical Biomarker Research Into Clinical Study Design
9. National Eye Institute hosts Translational Research and Vision Symposium
10. Momentum builds after 4th International Symposium on Pet Contraception
11. Symposium: Implications for the future of personalize medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2017)... MOUNTAIN VIEW, Calif. , March 9, ... Simple," and 23andMe , the leading personal genetics ... choices.  Zipongo can now provide customers with personalized nutrition ... goals and biometrics, but also genetic markers impacting how ... Zipongo,s personalized food decision support platform uses biometrics ...
(Date:3/7/2017)...   HireVue , the leading provider of video ... best talent, faster, today announced the additions of ... Diana Kucer as Chief Marketing Officer (CMO). ... poised to drive continued growth in the company,s new ... record bookings in 2017. "Companies worldwide turn ...
(Date:3/2/2017)... -- Summary This report provides all the information ... and activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... provides an in-depth insight into the partnering activity of one ... demand company reports are prepared upon purchase to ensure inclusion ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... Research and Markets has announced the addition of ... offering. ... The Global Market for Bioproducts Should Reach $714.6 Billion ... of 8.9%, This research report quantifies the ... product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and herbal/botanicals), biocomposite ...
(Date:3/23/2017)... , March 23, 2017  GlobeImmune, Inc. today announced ... the sale of 12,835,490 shares of its common stock ... of companies. In connection with the sale of its common ... cash and issue to GlobeImmune 200,000 shares, an estimated ... "We are pleased to enter into this ...
(Date:3/23/2017)... Kineta, Inc., a biotechnology company focused ... immuno-oncology, today announced the discovery and characterization of ... activate interferon response factor 3 (IRF3) via RIG-I ... regression in a murine colon carcinoma mouse model.  ... tumor regression to initial drug treatment were resistant ...
(Date:3/23/2017)... March 23, 2017  Agriculture technology company Cool Planet ... and note conversion to commercialize its Cool Terra and ... on developing products that are simultaneously profitable as well ... the last 18 months. This latest round of funding ... Partners. The company,s primary product, Cool ...
Breaking Biology Technology: